SCHOTT PHARMA AG& CO KGAA (1SXP.DE) Stock Overview
Europe - FRA:1SXP - DE000A3ENQ51 - Common Stock
1SXP.DE Key Statistics, Chart & Performance
The current stock price of 1SXP.DE is 20.75 EUR. In the past month the price decreased by -2.79%. In the past year, price decreased by -29.53%.
1SXP.DE Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| TN8.DE | THERMO FISHER SCIENTIFIC INC | 24.68 | 174.63B | ||
| 1DHR.MI | DANAHER CORP | 28.53 | 131.68B | ||
| DAP.DE | DANAHER CORP | 27.88 | 128.77B | ||
| LO3.DE | LONZA GROUP AG-REG | 34.89 | 40.78B | ||
| QTS.DE | IQVIA HOLDINGS INC | 18.17 | 30.33B | ||
| DIM.PA | SARTORIUS STEDIM BIOTECH | 47.7 | 19.17B | ||
| 56S1.DE | SARTORIUS STEDIM BIOTECH | 47.7 | 19.17B | ||
| SRT3.DE | SARTORIUS AG-VORZUG | 50.97 | 16.60B | ||
| SRT.DE | SARTORIUS AG | 41.7 | 13.58B | ||
| ILU.DE | ILLUMINA INC | 23.42 | 12.82B | ||
| ESF0.DE | EUROFINS SCIENTIFIC | 17.31 | 11.35B | ||
| ERF.PA | EUROFINS SCIENTIFIC | 17.29 | 11.34B |
Related stock screener links
About 1SXP.DE
Company Profile
SCHOTT Pharma AG & Co. KgaA engages in the provision of designing drug containment and drug delivery solutions. The company is headquartered in Mainz, Hessen and currently employs 4,689 full-time employees. The company went IPO on 2023-09-28. The firm is primarily engaged in designing advanced drug containment solutions and drug delivery systems for the pharmaceutical and biotech industries. The Company’s portfolio ranges from syringes and cartridges to vials and ampoules, all made using Type I Borosilicate Glass and high-grade pharmaceutical polymer.
Company Info
SCHOTT PHARMA AG& CO KGAA
Hattenbergstrasse 10
MAINZ HESSEN DE
Employees: 4689
Phone: 496131660
SCHOTT PHARMA AG& CO KGAA / 1SXP.DE FAQ
What is the stock price of SCHOTT PHARMA AG& CO KGAA today?
The current stock price of 1SXP.DE is 20.75 EUR. The price decreased by -2.81% in the last trading session.
What is the ticker symbol for SCHOTT PHARMA AG& CO KGAA stock?
The exchange symbol of SCHOTT PHARMA AG& CO KGAA is 1SXP and it is listed on the Deutsche Boerse Ag exchange.
On which exchange is 1SXP.DE stock listed?
1SXP.DE stock is listed on the Deutsche Boerse Ag exchange.
What is the price forecast or stock price prediction for SCHOTT PHARMA AG& CO KGAA stock?
19 analysts have analysed 1SXP.DE and the average price target is 30.13 EUR. This implies a price increase of 45.2% is expected in the next year compared to the current price of 20.75. Check the SCHOTT PHARMA AG& CO KGAA stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is SCHOTT PHARMA AG& CO KGAA worth?
SCHOTT PHARMA AG& CO KGAA (1SXP.DE) has a market capitalization of 3.13B EUR. This makes 1SXP.DE a Mid Cap stock.
How many employees does SCHOTT PHARMA AG& CO KGAA have?
SCHOTT PHARMA AG& CO KGAA (1SXP.DE) currently has 4689 employees.
What are the support and resistance levels for SCHOTT PHARMA AG& CO KGAA (1SXP.DE) stock?
SCHOTT PHARMA AG& CO KGAA (1SXP.DE) has a resistance level at 21.3. Check the full technical report for a detailed analysis of 1SXP.DE support and resistance levels.
Is SCHOTT PHARMA AG& CO KGAA (1SXP.DE) expected to grow?
The Revenue of SCHOTT PHARMA AG& CO KGAA (1SXP.DE) is expected to grow by 2.61% in the next year. Check the estimates tab for more information on the 1SXP.DE EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy SCHOTT PHARMA AG& CO KGAA (1SXP.DE) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of 1SXP.DE, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of 1SXP.DE, evaluating the profitability, health, valuation and growth aspects
- SCHOTT PHARMA AG& CO KGAA (1SXP.DE) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- SCHOTT PHARMA AG& CO KGAA (1SXP.DE) Sales and EPS estimates to see what analysts future expectations are.
- SCHOTT PHARMA AG& CO KGAA (1SXP.DE) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- SCHOTT PHARMA AG& CO KGAA (1SXP.DE) Insider and Institutional Ownership to learn about the owners and their transactions.
- SCHOTT PHARMA AG& CO KGAA (1SXP.DE) Stock Chart to make your own analysis
- SCHOTT PHARMA AG& CO KGAA (1SXP.DE) Latest news and press-releases to stay up to date.
Does SCHOTT PHARMA AG& CO KGAA (1SXP.DE) stock pay dividends?
SCHOTT PHARMA AG& CO KGAA (1SXP.DE) has a dividend yield of 0.73%. The yearly dividend amount is currently 0.15. Check the full fundamental report for a detailed analysis of 1SXP.DE dividend history, reliability and sustainability.
When does SCHOTT PHARMA AG& CO KGAA (1SXP.DE) report earnings?
SCHOTT PHARMA AG& CO KGAA (1SXP.DE) will report earnings on 2025-12-11.
What is the Price/Earnings (PE) ratio of SCHOTT PHARMA AG& CO KGAA (1SXP.DE)?
The PE ratio for SCHOTT PHARMA AG& CO KGAA (1SXP.DE) is 21.39. This is based on the reported non-GAAP earnings per share of 0.97 and the current share price of 20.75 EUR. Check the full fundamental report for a full analysis of the valuation metrics for 1SXP.DE.
1SXP.DE Technical Analysis
1SXP.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to 1SXP.DE. 1SXP.DE scores excellent on profitability, but there are some minor concerns on its financial health.
1SXP.DE Financial Highlights
Over the last trailing twelve months 1SXP.DE reported a non-GAAP Earnings per Share(EPS) of 0.97. The EPS decreased by -3% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 15.05% | ||
| ROA | 9.61% | ||
| ROE | 17.01% | ||
| Debt/Equity | 0.09 |
1SXP.DE Forecast & Estimates
19 analysts have analysed 1SXP.DE and the average price target is 30.13 EUR. This implies a price increase of 45.2% is expected in the next year compared to the current price of 20.75.
For the next year, analysts expect an EPS growth of 4.98% and a revenue growth 2.61% for 1SXP.DE